Literature DB >> 7797549

Spectroscopic studies of the characterization of recombinant human dihydrolipoamide dehydrogenase and its site-directed mutants.

T C Liu1, L G Korotchkina, S L Hyatt, N N Vettakkorumakankav, M S Patel.   

Abstract

In this paper, we report the overexpression and single-step purification of recombinant wild-type and site-directed mutants of human dihydrolipoamide dehydrogenase in Escherichia coli and detailed spectroscopic studies aimed at understanding the catalytic mechanism of this enzyme. One mutation (K37E) has been identified in a patient lacking dihydrolipoamide dehydrogenase activity and has been reported previously (Liu, T.-C., Kim, H., Arizmendi, C., Kitano, A., and Patel, M. S. (1993) Proc. Natl. Acad. Sci. USA. 90, 5186-5190), while the other two mutations were previously generated specifically to address the role of the active-site base (His-452) and its ion pair (Glu-457). Circular dichroic and fluorescence spectroscopic data illustrate the role of these amino acids in maintaining the structure and function of human dihydrolipoamide dehydrogenase. While mutant H452Q is severely crippled in catalysis of the physiological reaction, the reverse reaction is affected in the E457Q mutant. The K37E mutant shows very little deviation from the wild-type enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797549     DOI: 10.1074/jbc.270.26.15545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Furoates and thenoates inhibit pyruvate dehydrogenase kinase 2 allosterically by binding to its pyruvate regulatory site.

Authors:  Tiziana Masini; Barbara Birkaya; Simon van Dijk; Milon Mondal; Johan Hekelaar; Manuel Jäger; Anke C Terwisscha van Scheltinga; Mulchand S Patel; Anna K H Hirsch; Edelmiro Moman
Journal:  J Enzyme Inhib Med Chem       Date:  2016-07-19       Impact factor: 5.051

2.  Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the αV138M variant of human pyruvate dehydrogenase.

Authors:  Matthew J Whitley; Palaniappa Arjunan; Natalia S Nemeria; Lioubov G Korotchkina; Yun-Hee Park; Mulchand S Patel; Frank Jordan; William Furey
Journal:  J Biol Chem       Date:  2018-07-03       Impact factor: 5.157

3.  Interaction of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase complex.

Authors:  Mulchand S Patel; Lioubov G Korotchkina; Sukhdeep Sidhu
Journal:  J Mol Catal B Enzym       Date:  2009-11-01

4.  Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial lipoamide dehydrogenase .

Authors:  Ruslana Bryk; Nancy Arango; Aditya Venugopal; J David Warren; Yun-Hee Park; Mulchand S Patel; Christopher D Lima; Carl Nathan
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

5.  Human 2-oxoglutarate dehydrogenase complex E1 component forms a thiamin-derived radical by aerobic oxidation of the enamine intermediate.

Authors:  Natalia S Nemeria; Attila Ambrus; Hetalben Patel; Gary Gerfen; Vera Adam-Vizi; Laszlo Tretter; Jieyu Zhou; Junjie Wang; Frank Jordan
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

6.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency.

Authors:  Attila Ambrus; Junjie Wang; Reka Mizsei; Zsofia Zambo; Beata Torocsik; Frank Jordan; Vera Adam-Vizi
Journal:  Biochim Biophys Acta       Date:  2016-08-18

7.  Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.

Authors:  Rosa Ferriero; Clara Iannuzzi; Giuseppe Manco; Nicola Brunetti-Pierri
Journal:  J Inherit Metab Dis       Date:  2015-01-20       Impact factor: 4.982

8.  Structural alterations by five disease-causing mutations in the low-pH conformation of human dihydrolipoamide dehydrogenase (hLADH) analyzed by molecular dynamics - Implications in functional loss and modulation of reactive oxygen species generation by pathogenic hLADH forms.

Authors:  Attila Ambrus; Reka Mizsei; Vera Adam-Vizi
Journal:  Biochem Biophys Rep       Date:  2015-05-07

Review 9.  An Updated View on the Molecular Pathomechanisms of Human Dihydrolipoamide Dehydrogenase Deficiency in Light of Novel Crystallographic Evidence.

Authors:  Attila Ambrus
Journal:  Neurochem Res       Date:  2019-03-07       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.